ITALY |MI |EUR
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Shares Outstanding | Beta | 0.98 | |
---|---|---|---|
Public Float | P/E Ratio | 5.29 | |
% Short of Float | - | Dividend (Yield) | 3.85 (0.05%) |
Held by Insiders | 1.76% | Ex-Dividend Date | Mar 21, 2022 |
Held by Institutions | 9.16% | IPO Date | - |
Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|
Revenue | €-396.22M | €699.23M | €685.24M |
EBITDA | € | € | € |
Net Income | €-404.81M | €691.17M | €677.43M |
Total Assets | €3.64B | €3.96B | €3.55B |
Total Cash | €2.83M | €6.82M | €30.71M |
Total Debt | € | € | € |
Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|
Revenue | €-298.02M | € | € |
EBITDA | € | € | € |
Net Income | €-299.86M | € | € |
Total Assets | €3.12B | € | € |
Total Cash | €1.64M | € | € |
Total Debt | € | € | € |
Bb biotech trades on the Milan stock market in Italy under the ticker symbol "BB". Bb biotech’s stock symbol can also be displayed as "BIT:BB".
Bb biotech (BIT:BB) is owned by 9.16% institutional shareholders and by 1.76% insiders. The rest is owned by the public.
Explore More Details on Bb biotech's “Ownership” Section
Bb biotech (BIT:BB) is owned by 9.16% institutional shareholders and by 1.76% insiders. The rest is owned by the public.
Explore More Details on Bb biotech's “Ownership” Section
Bb biotech (BIT:BB) is classified under the "Healthcare" sector and under the "Biotechnology" industry.
ESG scores assess the degree to which a company’s enterprise business value is at risk driven by environmental, social, and governance issues. The scores are a measure of risk on an absolute scale of 0-100, with a lower score meaning less risk.
BB’s total ESG score is 33.40. The company’s environmental score is 6.00, social score is 6.00 and governance score is 6.00.
Currently the number of employees working for Bb biotech is 10.
Bb biotech (BIT:BB) is headquartered in Switzerland.
Bb biotech’s mailing address is Seestrasse 16, Kusnacht, Switzerland, 8700.
The company’s phone number is 41 44 267 67 00.